The stock of DENTSPLY Sirona Inc (XRAY) has seen a -0.67% decrease in the past week, with a -17.45% drop in the past month, and a -24.11% decrease in the past quarter. The volatility ratio for the week is 2.44%, and the volatility levels for the past 30 days are at 3.72% for XRAY. The simple moving average for the past 20 days is 1.55% for XRAY’s stock, with a -27.68% simple moving average for the past 200 days.
Is It Worth Investing in DENTSPLY Sirona Inc (NASDAQ: XRAY) Right Now?
The stock has a 36-month beta value of 0.97. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 4 as “overweight,” 7 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for XRAY is 197.58M, and at present, short sellers hold a 5.01% of that float. On December 04, 2024, the average trading volume of XRAY was 3.05M shares.
XRAY) stock’s latest price update
The stock of DENTSPLY Sirona Inc (NASDAQ: XRAY) has decreased by -2.17 when compared to last closing price of 19.82. Despite this, the company has experienced a -0.67% fall in its stock price over the last five trading sessions. globenewswire.com reported 2024-12-03 that NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against DENTSPLY SIRONA Inc. (“Dentsply” or the “Company”) (NASDAQ:XRAY) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Dentsply securities between December 1, 2022 and November 6 2024, both dates inclusive (the “Class Period”). Investors have until January 27, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Analysts’ Opinion of XRAY
Needham, on the other hand, stated in their research note that they expect to see XRAY reach a price target of $29, previously predicting the price at $34. The rating they have provided for XRAY stocks is “Buy” according to the report published on October 25th, 2024.
Needham gave a rating of “Buy” to XRAY, setting the target price at $34 in the report published on August 20th of the current year.
XRAY Trading at -13.52% from the 50-Day Moving Average
After a stumble in the market that brought XRAY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -48.43% of loss for the given period.
Volatility was left at 3.72%, however, over the last 30 days, the volatility rate increased by 2.44%, as shares sank -16.92% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -25.91% lower at present.
During the last 5 trading sessions, XRAY fell by -0.67%, which changed the moving average for the period of 200-days by -42.26% in comparison to the 20-day moving average, which settled at $19.09. In addition, DENTSPLY Sirona Inc saw -45.52% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at XRAY starting from LUCIER GREGORY T, who purchase 5,000 shares at the price of $18.37 back on Nov 18 ’24. After this action, LUCIER GREGORY T now owns 71,730 shares of DENTSPLY Sirona Inc, valued at $91,850 using the latest closing price.
LUCIER GREGORY T, the Director of DENTSPLY Sirona Inc, purchase 1,000 shares at $18.28 during a trade that took place back on Nov 15 ’24, which means that LUCIER GREGORY T is holding 16,000 shares at $18,279 based on the most recent closing price.
Stock Fundamentals for XRAY
Current profitability levels for the company are sitting at:
- -0.07 for the present operating margin
- 0.52 for the gross margin
The net margin for DENTSPLY Sirona Inc stands at -0.11. The total capital return value is set at -0.05. Equity return is now at value -14.08, with -5.97 for asset returns.
Based on DENTSPLY Sirona Inc (XRAY), the company’s capital structure generated 0.47 points at debt to capital in total, while cash flow to debt ratio is standing at 0.24. The debt to equity ratio resting at 0.89. The interest coverage ratio of the stock is -3.61.
Currently, EBITDA for the company is 232.0 million with net debt to EBITDA at 25.95. When we switch over and look at the enterprise to sales, we see a ratio of 1.51. The receivables turnover for the company is 5.81for trailing twelve months and the total asset turnover is 0.59. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.25.
Conclusion
To sum up, DENTSPLY Sirona Inc (XRAY) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
